The eye care technology is a value addition to the ophthalmic applications especially for the treatment of dry eye.
Ojas Eye Hospital has brought home Lumenis M22 Optimal Pulse Technology (OPT) for treatment of dry eyes. The eye care technology is a value addition to the ophthalmic applications especially for the treatment of dry eye.
Lumenis is an energy-based medical device company. Reportedly, M22 is the answer to a majority of eye inflammation treatments with OPT being the advanced IPL technology, developed by Lumenis. M22 services will
be available at Ojas Eye Hospitals at Bandra and Kandivali.
Commenting on the development, Dr Niteen Dedhia, Medical Director, OJAS Eye Hospital said “M22 is a latest state of the art eye care technology. Most recent case studies and researches have showcased prevalence of dry eye among patients ranging across age groups. The introduction of M22 OPT technology will be a path breaker and a great relief to patients who have been prescribed to eye drops, the only available solution to treat dryness.”
“Our path breaking technology will help address the growing dry eye disease among thousands of people,” said Dharmendra Mistry, Country Head of Lumenis India, “We are happy to partner with Dr Niteen Dedhia, who is a veteran ophthalmologist and medical director at OJAS Eye Hospital. Entering in the western market is part of our expansion strategy ensuring the increasing number of patients who will be benefited from our latest OPT technology,” he said.
- Advertisement -
Comments are closed.